Hyperliquid Strategies Inc (NASDAQ:PURR - Get Free Report)'s stock price fell 5.6% on Tuesday . The stock traded as low as $11.23 and last traded at $11.5580. 8,357,166 shares changed hands during trading, a decline of 17% from the average daily volume of 10,087,396 shares. The stock had previously closed at $12.25.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on the company. Cantor Fitzgerald set a $22.60 target price on Hyperliquid Strategies and gave the stock an "overweight" rating in a research note on Thursday. Chardan Capital upped their price objective on shares of Hyperliquid Strategies from $9.75 to $17.00 and gave the company a "buy" rating in a report on Friday. Wall Street Zen downgraded shares of Hyperliquid Strategies from a "hold" rating to a "sell" rating in a research report on Saturday. Finally, Weiss Ratings raised shares of Hyperliquid Strategies from a "sell (d+)" rating to a "hold (c)" rating in a report on Friday. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $16.53.
Check Out Our Latest Report on PURR
Hyperliquid Strategies Stock Performance
The stock has a fifty day moving average price of $7.92 and a 200 day moving average price of $6.94. The stock has a market cap of $1.61 billion, a PE ratio of -1.51 and a beta of 1.71.
Institutional Investors Weigh In On Hyperliquid Strategies
A number of institutional investors and hedge funds have recently modified their holdings of the company. Amundi purchased a new position in Hyperliquid Strategies during the 2nd quarter worth approximately $190,000. California State Teachers Retirement System acquired a new position in shares of Hyperliquid Strategies in the 2nd quarter valued at about $107,000. SPX Gestao de Recursos Ltda acquired a new position in shares of Hyperliquid Strategies in the second quarter worth about $860,000. Wellington Management Group LLP purchased a new stake in shares of Hyperliquid Strategies in the second quarter valued at approximately $716,000. Finally, Paradigm Operations LP acquired a new position in Hyperliquid Strategies during the second quarter worth $44,936,535. Institutional investors and hedge funds own 9.45% of the company's stock.
Hyperliquid Strategies Company Profile
(
Get Free Report)
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Hyperliquid Strategies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperliquid Strategies wasn't on the list.
While Hyperliquid Strategies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.